Erlotinib Hydrochloride CAS 183319-69-9 Kemurnian >99,0% (HPLC)
Produsen utama lan pemasok Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-siji CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Jeneng Kimia | Erlotinib hidroklorida |
sinonim | Erlotinib HCl;Tarceva;CP-358774 Hidroklorida;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline Hydrochloride;N-(3-Ethynylphe nyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amin HCl |
Nomer CAS | 183319-69-9 |
Nomer CAT | RF-PI2242 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C22H24ClN3O4 |
Bobot Molekul | 429.90 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Kristal Putih nganti Putih |
Identifikasi | A: IR: Conresponding to Reference Spectrum B: HPLC: Jumbuh karo Referensi RT |
Kelarutan | Rada Larut ing Banyu, Rada Larut ing Metanol lan Praktis Ora Larut ing Acetonitrile, Aseton, Etil Asetat lan Heksana |
Titik Lebur | 223,0 ~ 229,0 ℃ |
Mundhut ing Pangatusan | <0,50% |
Sisa ing Ignition | <0,20% |
Logam abot | <20 ppm |
Impurity Tunggal | <0,50% |
Total Impurities | <1.00% |
Sisa Solvents | |
Piridin | <4000ppm |
Kloroform | <4000ppm |
DMF | <3000ppm |
Kemurnian / Metode Analisis | > 99.0% |
Metode Assay/Analisis | 98,5%~101,0% (Kakulasi ing Basis Anhidrat) |
Test Standar | Standar Perusahaan |
Panggunaan | API |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
Erlotinib Hydrochloride (CAS: 183319-69-9) minangka molekul cilik reseptor faktor pertumbuhan epidermis tirosin kinase inhibitor sing bisa dibalik, utamane digunakake ing perawatan kanker paru-paru sel cilik sing ora metastatik utawa metastatik lan perawatan baris kapindho utawa telung baris. kanker pankreas.Erlotinib Hydrochloride disetujoni ing Nopember, 2004, kanggo perawatan kanker paru-paru non-sel cilik sing maju utawa metastatik.Iki kalebu kelas sing padha karo Gefitinib, quinazoline liyane sing disetujoni kanggo perawatan kanker paru-paru lanjut, nanging kanthi sifat farmakokinetik sing luwih apik.Molekul kasebut asale saka Pfizer lan pembangunan diwiwiti kanthi kolaborasi karo OSI, sing nduweni hak lengkap kanggo obat kasebut nalika Pfizer gabung karo Warner Lambert.Sabanjure, Genentech/Roche mlebu perjanjian lisensi karo OSI kanggo ngembangake lan pasar obat kasebut ing AS lan Donya.Selective epidermal growth factor receptor (EGFR)-tirosin kinase inhibitor.Antineoplastik.Erlotinib Hydrochloride minangka inhibitor HER1 / EGFR kanthi IC50 saka 2 nM.Erlotinib HCl kasedhiya minangka tablet 25-, 100-, lan 150-mg kanggo administrasi oral.